Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Dognosis is seeking a Clinician In-Residence to provide medical insight across product, clinical operations, regulatory strategy, patient experience, and research as we scale breath-based cancer detection. You will be embedded across functions, shaping study protocols under ICH-GCP/Indian GCP, ensuring scientific rigor, and building medical foundations for a consumer screening product tomorrow.
Collaborate with hospitals and researchers; participate in a dynamic, flexible startup culture with
As our Clinician In-Residence, you will be the medical voice across product, clinical operations, regulatory strategy, patient experience, and research as we bring breath-based cancer detection to the world.
Dognosis is a deeptech company devoted to unleashing the superpowers of humanity's best friends. We build brain-computer interfaces, wearable sensors, robotic platforms and AI models to standardise, scale and augment canine olfaction. Our focus is a breath-based multi-cancer test that triages risk at population scale, so early cancer detection can reach everyone. Our mission is informed peace of mind for people and their companions, through interspecies technology that makes medicine truly proactive. We are based in Bengaluru, India, backed by Boost VC and 1517 Fund, selected for the Accel and Prosus Atoms X LeapTech cohort, and we work with healthcare and research institutions across India, the UK and the US.
We think from first principles, question the status quo, take responsibility, move fast and keep bureaucracy to a minimum. If you are new to startups, you may find the constant contact with reality, and the freedom to act on it, refreshing.
As our Clinician In-Residence, you will be the medical voice across product, clinical operations, regulatory strategy, patient experience, and research as we bring breath-based cancer detection to the world.
This is a cross-functional medical role, involving work across product, clinical operations, medical affairs, regulatory, patient experience, and research. Dognosis runs a multi-site prospective clinical study under ICH-GCP and Indian GCP compliance, and is preparing for commercial rollout. You will be embedded across both: shaping protocols and ensuring scientific rigor today, and helping build the medical foundation for a consumer screening product tomorrow.
Nice to have